-
William J.E.Frye，Lyn M.Huff，JoséM.González Dalmasy，Paula Salazar，Rachel M.Carter，Ryan T.Gensler，Dominic Esposito，Robert W.Robey，Suresh V.Ambudkar，Michael M.Gottesman（Laboratory of Cell Biology；Protein Expression Laboratory）.The multidrug resistance transporter P-glycoprotein confers resistance to ferroptosis inducers[J].癌症耐药(英文),2023,第3期
-
Sara Bouberhan，Liron Bar-Peled，Yusuke Matoba，Varvara Mazina，Lauren Philp，Bo R.eda（Division of Hematology/Oncology；Department of Medicine；Center for Cancer Research；Department of Obstetrics and Gynecology；Obstetrics；Division of Gynecologic Oncology）.The evolving role of DNA damage response in overcoming therapeutic resistance in ovarian cancer[J].癌症耐药(英文),2023,第2期
-
Sandra Martínez-Martín，Marie-Eve Beaulieu，Laura Soucek（Peptomyc S.L.；Preclinical&Translational Research Program；Department of Biochemistry and Molecular Biology；InstitucióCatalana de Recerca i Estudis Avançats（ICREA））.Targeting MYC-driven lymphoma：lessons learned and future directions[J].癌症耐药(英文),2023,第2期
-
Salvatore Perrone，Tiziana Ottone，Nadezda Zhdanovskaya，Matteo Molica（Hematology；Department of Biomedicine and Prevention；Neuro-Oncohematology；Hematology；Hematology Unit）.How acute myeloid leukemia(AML)escapes from FMS-related tyrosine kinase 3(FLT3)inhibitors?Still an overrated complication?[J].癌症耐药(英文),2023,第2期
-
Sylvain Garciaz，Thomas Miller，Yves Collette，Norbert Vey（Hematology Department；Integrative Structural and Chemical Biology；Hematology Department）.Targeting regulated cell death pathways in acutemyeloid eukemia[J].癌症耐药(英文),2023,第1期
|